You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
常茂生物(00954.HK):預計年度綜合淨利1400萬至2100萬元
格隆匯 03-17 16:37

格隆匯 3 月 17日丨常茂生物(00954.HK)發佈公吿,如2020盈利警吿公吿中所披露的,其中包括,集團預期在截至2020年12月31日止年度,將對連雲港常茂的物業、機器及設備做出減值準備及部份遞延税項資產予以沖銷。

集團大致上完成了減值損失和遞延税項資產沖銷的評估;並且經評估目前所得資料後,集團很有可能錄得截至2020年12月31日止年度歸屬於公司權益持有人的綜合淨利潤約人民幣1400萬元至人民幣2100萬元,將較2019年度歸屬於公司權益持有人的綜合淨利潤約人民幣5829.9萬元大幅下降。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account